{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:18:27Z","timestamp":1787836707977,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","award":["IRF-7-21"],"award-info":[{"award-number":["IRF-7-21"]}],"id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current guidelines for diabetic ketoacidosis (DKA) recommend treatment with normal saline (NS). However, NS, with its high chloride concentrations, may worsen acidosis and contribute to a hyperchloremic metabolic acidosis. Alternatives to NS are balanced crystalloids (e.g. Ringer\u2019s Lactate [RL]) which have chloride concentrations similar to human plasma; therefore, treatment with balanced crystalloids may lead to faster DKA resolution. A recent systematic review and meta-analysis by Catahay et al<jats:italic>.<\/jats:italic> (2022) demonstrated the need for more blinded, high-quality trials comparing NS versus RL in the treatment of DKA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We describe a protocol for BRISK-ED (Balanced crystalloids [RInger\u2019s lactate] versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department). Our study is a single-centre, triple-blind, pilot randomized controlled trial (RCT) of adults (\u2265\u200918\u00a0years) with DKA presenting to an academic tertiary care ED in London, Canada.<\/jats:p>\n                <jats:p>Patients with clinical suspicion for DKA will be screened and those found to not meet DKA criteria or have euglycemic DKA will be excluded. We will aim to recruit 52 patients with DKA and will randomize them 1:1 to receive intravenous RL or NS.<\/jats:p>\n                <jats:p>The primary feasibility outcome will be recruitment rate, and the primary efficacy outcome will be time elapsed from ED presentation to DKA resolution. Secondary outcomes include time to insulin infusion discontinuation, intensive care unit admission, in-hospital death, and major adverse kidney events within 30\u00a0days, defined as a composite of: i) death, ii) new renal replacement therapy, or iii) final serum creatinine\u2009\u2265\u2009200% baseline at the earliest of hospital discharge or 30\u00a0days after ED presentation. Patients, clinicians, and outcome assessors will be blinded to allocation group. We will follow an intention-to-treat analysis. Gehan-Wilcoxon, Mann\u2013Whitney U, or chi-square tests will be used to compare groups as appropriate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The results of this pilot study will inform the design and feasibility of a full-scale, multicentre RCT to assess fluid choice in adult ED patients with DKA. If proven to demonstrate faster resolution of DKA, administration of balanced crystalloids may replace NS in diabetes treatment guidelines and improve patient and health systems outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov, Registration # NCT04926740; Registered June 15, 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40814-023-01356-5","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T10:03:54Z","timestamp":1689242634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Balanced crystalloids (RInger\u2019s lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a protocol for a pilot randomized controlled trial"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5124","authenticated-orcid":false,"given":"Justin W.","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Slim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Van Aarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Poonai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin K.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"7","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335\u201343. https:\/\/doi.org\/10.2337\/dc09-9032.","journal-title":"Diabetes Care"},{"key":"1356_CR2","unstructured":"Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults, 2nd edition. Published 2013. Accessed 18 Jan 2021. https:\/\/abcd.care\/resource\/management-diabetic-ketoacidosis-dka-adults."},{"issue":"suppl","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jcjd.2017.10.013","volume":"42(1)","author":"J Goguen","year":"2018","unstructured":"Goguen J, Gilbert J, Diabetes Canada Clinical Practice Guidelines Expert Committee. Hyperglycemic emergencies in adults. Can J Diabetes. 2018;42(1)(suppl):109\u201314. https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.013.","journal-title":"Can J Diabetes."},{"issue":"13","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMra1208627","volume":"369","author":"JA Myburgh","year":"2013","unstructured":"Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243\u201351. https:\/\/doi.org\/10.1056\/NEJMra1208627.","journal-title":"N Engl J Med"},{"issue":"6","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MCC.0000000000000551","volume":"24","author":"JD Casey","year":"2018","unstructured":"Casey JD, Brown RM, Semler MW. Resuscitation fluids. Curr Opin Crit Care. 2018;24(6):512\u20138. https:\/\/doi.org\/10.1097\/MCC.0000000000000551.","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00134-004-2176-x","volume":"30","author":"TJ Morgan","year":"2004","unstructured":"Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med. 2004;30(7):1432\u20137. https:\/\/doi.org\/10.1007\/s00134-004-2176-x.","journal-title":"Intensive Care Med"},{"issue":"5","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0885066610371633","volume":"25","author":"EM Omron","year":"2010","unstructured":"Omron EM, Omron RM. A physicochemical model of crystalloid infusion on acid-base status. J Intensive Care Med. 2010;25(5):271\u201380. https:\/\/doi.org\/10.1177\/0885066610371633.","journal-title":"J Intensive Care Med"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.hrtlng.2022.03.014","volume":"54","author":"JA Catahay","year":"2022","unstructured":"Catahay JA, Polintan ET, Casimiro M, et al. Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: a systematic review and meta-analysis. Heart Lung. 2022;54:77\u20139.","journal-title":"Heart Lung"},{"issue":"4","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/qjmed\/hcr226","volume":"105","author":"DG VanZyl","year":"2012","unstructured":"VanZyl DG, Rheeder P, Delport E. Fluid management in diabetic-acidosis\u2014Ringer\u2019s lactate versus normal saline: a randomized controlled trial. QJM. 2012;105(4):337\u201343. https:\/\/doi.org\/10.1093\/qjmed\/hcr226.","journal-title":"QJM"},{"issue":"11","key":"1356_CR10","doi-asserted-by":"publisher","first-page":"e2024596","DOI":"10.1001\/jamanetworkopen.2020.24596","volume":"3","author":"WH Self","year":"2020","unstructured":"Self WH, Evans CS, Jenkins CA, et al. Clinical effects of balanced crystalloid vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials. JAMA Network Open. 2020;3(11):e2024596. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.24596.","journal-title":"JAMA Network Open."},{"key":"1356_CR11","first-page":"1248","volume":"47","author":"M Ramanan","year":"2021","unstructured":"Ramanan M, Attokaran A, Murray L, et al. Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial. Intensive Care Med. 2021;47:1248\u201357.","journal-title":"Intensive Care Med"},{"issue":"9","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1711584.","journal-title":"N Engl J Med."},{"issue":"9","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1711586","volume":"378","author":"WH Self","year":"2018","unstructured":"Self WH, Semler MW, Wanderer JP, et al. Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018;378(9):819\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1711586.","journal-title":"N Engl J Med."},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: Defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, et al. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"1356_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40814-016-0105-8","volume":"2","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2:64.","journal-title":"Pilot Feasibility Stud"},{"issue":"1S","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.chest.2020.03.010","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang X, Ji X. Sample size estimation in clinical research: from randomized controlled trials to observational studies. Chest. 2020;158(1S):S12\u201320. https:\/\/doi.org\/10.1016\/j.chest.2020.03.010.","journal-title":"Chest"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-023-01356-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T10:06:59Z","timestamp":1689242819000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01356-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s40814-023-01356-5","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this trial was obtained from Western University\u2019s Health Sciences Research Ethics Board (ID# 119430). In accordance with best practices from our Research Ethics Board, informed verbal consent from all participants will be obtained by emergency physicians or trained research staff prior to study enrolment. Any protocol changes will be communicated to the Research Ethics Board per existing guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Outside of this study, KC has received a research award sponsored in part by Astra Zeneca. She has attended conferences sponsored by Merck. She has received honoraria for delivering certified medical education from Sutherland Global Services Canada ULC, the Canadian Medical and Surgical Knowledge Translation Group and the CPD Network.There are no other conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}